Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Tuberc Lung Dis ; 8(7): 816-23, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15260271

ABSTRACT

SETTING: A tuberculosis control project in Bangladesh. OBJECTIVE: To document the frequency and diagnostic value of smears with scanty acid-fast bacilli (AFB) (IUATLD/WHO scale, < 10/100 high power fields), and to assess the appropriateness of the current positivity threshold. DESIGN: Analysis of databases of laboratory registers, patient records and the diagnostic yield of sputum collection strategies. RESULTS: Scanty smears constituted about 10% of suspect and almost 50% of follow-up smears. In suspect series, 10% of scanty 1-9/100 were not confirmed by another positive or scanty AFB sputum, compared to 7.5% of results at the current cut-off value of 10/100. Considering such results as positive by adopting a lower cut-off as low as the 1/100 used in the ATS scale added 1.5% false positives at the most. In return, the gain in confirmed positive cases was up to 10%, and that in positive results exceeded the incremental yield of the third diagnostic sputum. Significance of scanty follow-up smears at the end of the intensive phase was suggested by their association with treatment failure and unfavourable outcome overall. CONCLUSIONS: Scanty results (IUATLD/WHO scale) are not rare and should not be ignored. Adoption of a considerably lower positivity threshold would be appropriate in control programmes where basic conditions for reliable AFB microscopy, including regular quality assessment, are present.


Subject(s)
Sputum/cytology , Tuberculosis, Pulmonary/diagnosis , Bacteriological Techniques , Bangladesh , Humans , Microscopy , Prognosis , Reference Values , Sensitivity and Specificity , Specimen Handling , Treatment Outcome , Tuberculosis, Pulmonary/therapy , World Health Organization
2.
Int J Tuberc Lung Dis ; 8(1): 23-30, 2004 Jan.
Article in English | MEDLINE | ID: mdl-14974742

ABSTRACT

SETTING: Greater Mymensingh District, Bangladesh. OBJECTIVES: To determine changes in prevalence of drug resistance of Mycobacterium tuberculosis under DOTS. DESIGN: Drug susceptibility testing of systematic samples of M. tuberculosis isolated from all sputum smear-positive cases newly registered in sentinel centres during 1995 and 2001. Continuous monitoring of retreatment registrations and resistance of strains from relapse and failure cases. RESULTS: Of 942 strains from the new cases in 2001, 10.8% showed resistance to any drug, 6.2% to isoniazid, 0.4% to rifampicin (all of them multidrug-resistant, MDR), 7.1% to streptomycin, and 1.0% to ethambutol. Corresponding rates for 99 strains from previously treated cases were 32%, 20%, 3%, 20% and 2%, respectively. Although most rates of resistance had decreased since 1995, increased streptomycin resistance was the only significant change when new and previously treated cases were considered separately. However, combined resistance for any drug, isoniazid, rifampicin and MDR had decreased significantly. CONCLUSION: As suggested by monitoring of resistance in failure and relapse cases and by routine programme reports, drug resistance had decreased. Combined resistance demonstrated changes between periodic surveys better than its subgroups, and may be a more reliable and comprehensive indicator. However, continuous monitoring of the pool of resistant retreatment cases is a more efficient strategy.


Subject(s)
Antitubercular Agents/pharmacology , Mycobacterium tuberculosis/drug effects , Primary Prevention/organization & administration , Tuberculosis/drug therapy , Tuberculosis/prevention & control , Antitubercular Agents/therapeutic use , Bangladesh/epidemiology , Developing Countries , Drug Resistance, Bacterial , Female , Humans , Male , Microbial Sensitivity Tests , Molecular Epidemiology , Monitoring, Physiologic , Mycobacterium tuberculosis/isolation & purification , Population Surveillance , Prevalence , Program Evaluation , Recurrence , Retrospective Studies , Risk Assessment , Treatment Outcome , Tuberculosis/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...